Summary:
In adults with type 2 diabetes, Dibifree, a dietary phytomix (15 g/day) significantly improved glycemic control and reduced adiposity compared to placebo, though it was associated with mild gastrointestinal side effects.
| PICO | Description |
|---|---|
| Population | Adults diagnosed with type 2 diabetes participating in a 7-month randomized controlled trial. |
| Intervention | Dibifree dietary phytomix administered at 15 g/day as an add-on treatment. |
| Comparison | Placebo administered under identical conditions. |
| Outcome | Dibifree significantly improved glycemic control as evidenced by reductions in HbA1c and fasting glucose, as well as decreased adiposity measured by body fat composition. The intervention modulated the gut-pancreas-adipose-immune axis. Mild gastrointestinal side effects were the main adverse events reported. |
Source: Tzu-Yi Huang, et al. “Dibifree, a dietary phytomix, improves glycemic control and adiposity via modulation of the gut-pancreas-adipose-immune axis in type 2 diabetes.” Read article here.
